Livasa Hospitals appoints Kamal Kant Gambhir as Chief Financial Officer S.A.S.Nagar 1 May ( Ranjeet Singh Dhaliwal ) : Livasa Hospitals has announced the appointment of Kamal Kant Gambhir as its Chief Financial Officer, further strengthening the leadership team as the hospital network continues its growth and expansion across North India. Gambhir brings with him over 35 years of rich experience in strategic finance, governance, business transformation, and leadership across healthcare, manufacturing, telecom, and multinational organizations. He has held key leadership roles with reputed organizations including SCL Lifesciences Limited as Chief Financial Officer and Gates, a US based multinational organisation, where he served as Senior Finance Director. Known for building robust financial systems, driving operational efficiency, and enabling sustainable business growth, Mr. Gambhir’s appointment comes at a significant time as Livasa Hospitals accelerates its expansion plans and strengt...
Union Minister J. P. Nadda visits NIPER, Mohali
S.A.S.Nagar 1 May ( Ranjeet Singh Dhaliwal ) : Jagat Prakash Nadda, Union Minister for Chemicals & Fertilizers and Health & Family Welfare, visited the National Institute of Pharmaceutical Education and Research (NIPER), Mohali on Friday, May 01, 2026. The Hon’ble Minister arrived at the NIPER Convention Centre where he was accompanied by Manoj Joshi, Secretary; Geetha Ashok, Under Secretary; and Dr. Kinny Singh, Deputy Secretary from the Department of Pharmaceuticals (DoP), Government of India.
A Board Room meeting was also organised, where the Director, NIPER Mohali, Prof. Dulal Panda, presented the institute’s vision, key performance indicators (KPIs), and strategic roadmap in the presence of senior officials and faculty members. The presentation highlighted key initiatives, including Centres of Excellence such as COE-AVAB and COE-Biopharmaceuticals, along with the institute’s innovation ecosystem and licensing opportunities. Prof. Panda emphasized that NIPER Mohali is driven by excellence in research, has nurtured a distinguished pool of alumni, and continues to contribute significantly to national development. He further highlighted the institute’s commitment to strengthening the Government of India’s Biopharma SHAKTI mission through advancements in Cell and Gene Therapies, biologics, biosimilars, medical devices, AI-driven pharmacoinformatics, and advanced drug delivery systems. To support this vision, NIPER Mohali has introduced two new Master’s programmes in Biopharmaceuticals and Regulatory Affairs.
Manoj Joshi interacted with faculty and students, inviting suggestions on enhancing industry collaboration, technology transfer, and translational research outcomes. He emphasized the need for reforms in the reward system to drive performance, suggesting incentives for faculty securing external funding and increasing industry-sponsored research. He also stressed the importance of transitioning from “paper patents” to real-world translation and commercialization to enhance national impact. Addressing the gathering, Hon’ble Minister Shri J. P. Nadda reiterated the Government’s vision of positioning India as a global leader in biopharmaceuticals, particularly in APIs, key starting materials, synthesis intermediates, and biologics. He assured full support for strengthening research infrastructure at NIPER Mohali and commended the institute for producing industry-ready professionals contributing to the nation’s growth. He concluded by assuring continued funding support and policy reforms to accelerate execution and innovation.The visit was followed by a Technology Showcase in the Convention Centre foyer, where the Hon’ble Minister reviewed posters and prototypes demonstrating translational research outcomes. The showcase featured industry collaborations, patents, and clinical trial initiatives undertaken by NIPER. The Hon’ble Minister also inaugurated the NIPER Medicinal Succulents Garden and concluded his visit with a tour of the institute’s state-of-the-art research facilities, interacting with students and researchers. This visit underscores the Government of India’s continued commitment to strengthening pharmaceutical education, fostering innovation, and advancing research and development in the biopharmaceutical sector.
Comments
Post a Comment